RSV, and influenza show continued safety and substantial effectiveness against hospitalization across various populations.
Hospital resource use by children with complex chronic conditions increased from 2000 to 2022 but decreased for children without.
The FDA began a safety review of RSV monoclonal antibody treatments for infants despite the products' safety records.
Andrew Nixon, HHS spokesperson, confirmed the FDA's investigation of the COVID-19 vaccine revealed in a recently leaked email.
Former CDC Chief Medical Officer Dr Debra Houry claimed the delay in the CDC's annual report on abortion was due to staff and budget cuts.
Active rash, ILD, and elevated NLR are factors associated with greater in-hospital morality in patients with dermatomyositis.
No significant differences in the safety or effectiveness of tralokinumab were observed by racial subgroup among patients with AD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback